Targeted SERS Imaging and Intraoperative Real-Time Elimination of Microscopic Tumors for Improved Breast-Conserving

Yu Wen1,2, Ruoxuan Liu1, Yangcenzi Xie1

  • 1School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, China.

Insights

This study introduces a novel surface-enhanced Raman scattering (SERS) surgical strategy for breast cancer. This technique precisely targets HER2+ tumors, enabling complete removal and preventing recurrence, significantly improving patient outcomes.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Nanotechnology

Background:

  • Breast-conserving surgery is preferred but risks tumor recurrence due to microscopic residual disease.
  • Accurate tumor margin delineation and complete microscopic tumor removal are critical for surgical success.

Purpose of the Study:

  • To develop and evaluate a surface-enhanced Raman scattering (SERS) surgical strategy for precise tumor margin delineation and intraoperative elimination of microscopic breast tumors.
  • To assess the efficacy of HER2-targeting SERS probes in suppressing tumor growth and enabling photothermal ablation.

Main Methods:

  • Development of multifunctional HER2-targeting SERS probes for sensitive detection and therapeutic intervention.
  • Application of SERS-guided surgical resection combined with intraoperative photothermal ablation in a HER2+ breast tumor mouse model.

Main Results:

  • The SERS strategy achieved precise delineation of tumor margins and real-time elimination of microscopic tumor foci.
  • Complete eradication of HER2+ breast tumors was demonstrated, resulting in 100% tumor-free survival in the mouse model.
  • The SERS probes exhibited ultrahigh sensitivity, HER2 expression suppression, cell proliferation inhibition, and effective photothermal ablation.

Conclusions:

  • The developed SERS surgical strategy offers a promising approach for complete surgical removal of HER2+ breast tumors, significantly reducing local recurrence.
  • This technique has the potential to improve outcomes and survival rates for patients undergoing breast-conserving surgery for HER2+ breast cancer.

Related Concept Videos